Test Price
1,800 AED✅ Home Collection Available
Neuronal (Paraneoplastic) Autoantibodies Profile in UAE | 1800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited processing using Line Blot Immunoassay.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic post-test results interpretation by a DHA-licensed General Practitioner.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Location: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DHA Facility License No. 1143.
Test Overview & Methodology
This comprehensive paraneoplastic autoantibody panel detects serum antibodies targeting neuronal antigens (Hu, Yo, Ri, CV2, Ma2/Ta, amphiphysin, CRMP5, and others) that are frequently associated with underlying malignancies. Our DHA-licensed laboratory employs Line Blot Immunoassay for high sensitivity and specificity, enabling prompt neurological and oncological workup in the UAE.
| Feature | Our Test (Neuronal Autoantibodies Profile) | Closest Alternative (Overseas Reference Lab) |
|---|---|---|
| Methodology | Line Blot / Immunoblot (ISO 9001:2015) | Indirect Immunofluorescence / ELISA |
| Turnaround Time | Same Day (if sample received by 9 AM) | 5–7 Working Days |
| Panel Coverage | Full profile (Amphiphysin, CV2, PNMA2 [Ma2/Ta], Ri, Yo, Hu, CRMP5, etc.) | Limited to selected antigens (often Hu, Yo, Ri only) |
| Price | 1,800 AED | ~2,200 AED + shipping |
| UAE Compliance | DHA Licensed (Facility: 1143) & ISO Certified | Variable; may lack local accreditation |
Physician Insight & Safety Protocols
“A paraneoplastic autoantibody result should always be interpreted within the full clinical context. While a positive finding may guide targeted cancer screening, a negative result does not entirely rule out malignancy. I advise patients to discuss any neurological symptoms—especially new-onset seizures, ataxia, or cognitive changes—with their referring specialist to ensure thorough evaluation.”
— Dr. Ajay Singh, DHA License: 36234132
Clinical Medication Advisory
Medication Safety Notice
Do not stop any prescribed treatments without consulting your physician. Immunosuppressive agents (e.g., corticosteroids, rituximab) may alter antibody levels; always inform your healthcare provider about all medications before testing.
Exclusion Criteria & Emergency Red Flags
- Active uncontrolled infection (fever >38°C) – postpone blood collection.
- Recent cancer surgery or chemotherapy within 2 weeks – discuss with your oncologist.
- Paediatric patients under 18 years: guardian consent and specialised paediatrician involvement required.
- ER Red Flags: Sudden severe neurological deterioration (seizures, respiratory distress, acute mental status changes) – seek immediate emergency care, not this test.
Patient FAQ & Clinical Guidance
1. What is the Neuronal (Paraneoplastic) Autoantibodies Profile test?
This blood test detects specific autoantibodies that are often associated with paraneoplastic neurological syndromes. A positive result may indicate an underlying cancer that requires further investigation, while a negative result can help exclude certain conditions.
2. How should I prepare for the test?
No special preparation is needed. You can eat and drink normally before your blood draw. Please inform the phlebotomist if you are taking any immunosuppressive medications.
3. When will I receive my results and what do they mean?
Results are available the same day if your sample is received by 9 AM. A DHA-licensed physician will provide a telephonic explanation of the findings, correlating them with your clinical history for informed decision-making.
UAE Regulatory & Data Privacy Adherence
This service complies with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring secure handling of your health information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing safe digital health practices.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – regulating clinical testing safety and patient consent.
- ISO 9001:2015 Quality Management System (Cert: INT/EGQ/2509DA/3139) and DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | Neuronal (Paraneoplastic) Autoantibodies Profile |
| Price (AED) | 1,800 AED |
| Turnaround Time | Same Day (sample by 9 AM) |
| Sample Type / Matrix | Serum (peripheral blood) |
| Methodology Used | Line Blot Immunoassay (Immunoblot) |
| ICD-10-CM Code | G13.0 (Paraneoplastic neuromyopathy and neuropathy), D49.9, C80.1 |
| LOINC Code | 33934-8 (Paraneoplastic autoantibodies panel - Serum) |
| DHA Facility License & Laboratory Address | DNA Labs UAE | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians